STRATA Skin Sciences, Inc. financial data

Symbol
SSKN on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
5 Walnut Grove Drive, Suite 140, Horsham, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Former names
MELA SCIENCES, INC. /NY (to 1/4/2016), ELECTRO OPTICAL SCIENCES INC /NY (to 4/30/2010)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 127 % +0.3%
Quick Ratio 29 % -22.1%
Debt-to-equity 253 % +55.5%
Return On Equity -69.6 % -94.6%
Return On Assets -19.7 % -44.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.17M shares -88.1%
Common Stock, Shares, Outstanding 3.51M shares -89.9%
Entity Public Float 17.3M USD +0.24%
Common Stock, Value, Issued 4K USD -88.6%
Weighted Average Number of Shares Outstanding, Basic 3.51M shares +0.51%
Weighted Average Number of Shares Outstanding, Diluted 3.51M shares +0.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 32.7M USD -8.66%
Cost of Revenue 15M USD +3.31%
Research and Development Expense 1.07M USD -20.7%
Selling and Marketing Expense 11.8M USD -19.5%
General and Administrative Expense 10M USD -4.65%
Costs and Expenses 25.2M USD -5.08%
Operating Income (Loss) -7.43M USD -42.9%
Nonoperating Income (Expense) -975K USD +48%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.49M USD -105%
Income Tax Expense (Benefit) -92K USD -246%
Net Income (Loss) Attributable to Parent -8.31M USD -16.5%
Earnings Per Share, Basic 0.54 USD/shares +96.7%
Earnings Per Share, Diluted 0.54 USD/shares +96.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.48M USD -39.3%
Accounts Receivable, after Allowance for Credit Loss, Current 3.98M USD -9.59%
Inventory, Net 2.69M USD -54.5%
Assets, Current 13.8M USD -34.9%
Property, Plant and Equipment, Net 11.1M USD +34%
Operating Lease, Right-of-Use Asset 1.43M USD +77.1%
Intangible Assets, Net (Excluding Goodwill) 6.33M USD -60.3%
Goodwill 6.52M USD -25.9%
Other Assets, Noncurrent 325K USD +358%
Assets 39.6M USD -28.3%
Accounts Payable, Current 2.89M USD -25.6%
Employee-related Liabilities, Current 1.97M USD -7.97%
Accrued Liabilities, Current 6.61M USD -1.83%
Contract with Customer, Liability, Current 2.26M USD -7.18%
Liabilities, Current 12.1M USD -14.1%
Contract with Customer, Liability, Noncurrent 361K USD -26.3%
Deferred Income Tax Liabilities, Net 186K USD -39.2%
Operating Lease, Liability, Noncurrent 1.08M USD +180%
Liabilities 30.1M USD -21.4%
Retained Earnings (Accumulated Deficit) -242M USD -3.57%
Stockholders' Equity Attributable to Parent 9.5M USD -43.8%
Liabilities and Equity 39.6M USD -28.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -804K USD +1.59%
Net Cash Provided by (Used in) Financing Activities -18K USD
Net Cash Provided by (Used in) Investing Activities -725K USD +59.5%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 3.51M shares -89.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.55M USD +40.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.82M USD -34.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 480K USD +99.2%
Deferred Tax Assets, Valuation Allowance 50.1M USD +2.31%
Deferred Tax Assets, Gross 51.2M USD +1.62%
Operating Lease, Liability 1.4M USD +79.2%
Depreciation 3.02M USD +17.8%
Payments to Acquire Property, Plant, and Equipment 725K USD -59.5%
Lessee, Operating Lease, Liability, to be Paid 1.85M USD +116%
Property, Plant and Equipment, Gross 36.5M USD +16.2%
Operating Lease, Liability, Current 313K USD -20.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 334K USD +71.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 463K USD +19.9%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 452K USD +487%
Lessee, Operating Lease, Liability, to be Paid, Year Three 290K USD +427%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 301K USD
Operating Lease, Payments 419K USD +10.8%
Additional Paid in Capital 251M USD +0.37%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.25M USD -22.4%
Depreciation, Depletion and Amortization 5.23M USD -15.1%
Deferred Tax Assets, Net of Valuation Allowance 1.05M USD -23.3%
Share-based Payment Arrangement, Expense 163K USD -53.7%
Interest Expense 1.88M USD +85.4%
Preferred Stock, Par or Stated Value Per Share 0.1 USD/shares 0%